A figure from the research shows the same section of neural dendrite at days 1, 5 and 10 of imaging. Arrows indicate spines that will be lost by the next imaging day, or that were added by that day.

For years, developing selective FGFE2/3 inhibitors has been hindered by the extreme structural similarity among FGFR family members, leading to toxicities and resistance with current therapies.